Literature DB >> 21098153

Redefining outcome of first seizures by acute illness.

Emily T Martin1, Tara Kerin, Dimitri A Christakis, Heidi K Blume, Sidney M Gospe, Jan Vinje, Michael D Bowen, Jon Gentsch, Danielle M Zerr.   

Abstract

BACKGROUND: Seizures are common in children, but the causes and recurrence risk for children with a nonfebrile first seizure remain poorly understood.
OBJECTIVE: In a prospective longitudinal study of children who presented with a first-time seizure, we investigated the viral etiology of associated infectious illnesses and sought to determine the risk of recurrent seizures stratified by fever and type of illness. PATIENTS AND METHODS: Children (aged 6 months to 6 years) were enrolled at the time of evaluation for their first seizure and followed monthly for up to 5 years. Seizure and illness data were collected through parent interviews and medical-record reviews. Stool, serum, and cerebrospinal fluid collected within 48 hours of the first seizure were evaluated for viral gastrointestinal pathogens.
RESULTS: Of the 117 children enrolled, 78 (67%) had febrile seizures, 34 (29%) had nonfebrile-illness seizures, and 5 (4%) had unprovoked seizures. Children with nonfebrile-illness seizures were more likely than those with febrile seizures to have acute gastroenteritis (47% and 28%, respectively; P = .05). No significant differences in seizure recurrence were found between children with or without a fever at first seizure. Children with acute gastroenteritis at first seizure, regardless of fever, had a lower risk of seizure recurrence compared with children with other acute illnesses (hazard ratio: 0.28; 95% confidence interval: 0.09-0.80).
CONCLUSIONS: Our results confirm the role of gastrointestinal illness as a distinguishing feature in childhood seizures. Children with this distinct presentation have a low rate of seizure recurrence and few neurologic complications.

Entities:  

Mesh:

Year:  2010        PMID: 21098153      PMCID: PMC3040576          DOI: 10.1542/peds.2010-1138

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Rotavirus encephalitis mimicking afebrile benign convulsions in infants.

Authors:  K Hongou; T Konishi; S Yagi; K Araki; T Miyawaki
Journal:  Pediatr Neurol       Date:  1998-04       Impact factor: 3.372

2.  Classification of benign infantile afebrile seizures.

Authors:  Takuya Tanabe; Keita Hara; Mitsuru Kashiwagi; Hiroshi Tamai
Journal:  Epilepsy Res       Date:  2006-06-30       Impact factor: 3.045

3.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Authors:  V Gouvea; R I Glass; P Woods; K Taniguchi; H F Clark; B Forrester; Z Y Fang
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children.

Authors:  Jane Kuypers; Nancy Wright; James Ferrenberg; Meei-Li Huang; Anne Cent; Lawrence Corey; Rhoda Morrow
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Characterization of rotavirus strains from newborns in New Delhi, India.

Authors:  B K Das; J R Gentsch; H G Cicirello; P A Woods; A Gupta; M Ramachandran; R Kumar; M K Bhan; R I Glass
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

6.  Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus.

Authors:  A Angelica Trujillo; Karen A McCaustland; Du-Ping Zheng; Leslie A Hadley; George Vaughn; Susan M Adams; Tamie Ando; Roger I Glass; Stephan S Monroe
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Nonfebrile illness seizures: a unique seizure category?

Authors:  Danielle M Zerr; Heidi K Blume; Anne T Berg; Mark A Del Beccaro; Sidney M Gospe; Amanda L Allpress; Dimitri A Christakis
Journal:  Epilepsia       Date:  2005-06       Impact factor: 5.864

8.  Assessing children's development using parents' reports. The Child Development Inventory.

Authors:  H Ireton; F P Glascoe
Journal:  Clin Pediatr (Phila)       Date:  1995-05       Impact factor: 1.168

9.  Identification of group A rotavirus gene 4 types by polymerase chain reaction.

Authors:  J R Gentsch; R I Glass; P Woods; V Gouvea; M Gorziglia; J Flores; B K Das; M K Bhan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

10.  Benign convulsions with mild gastroenteritis: a report of 10 recent cases detailing clinical varieties.

Authors:  H Komori; M Wada; M Eto; H Oki; K Aida; T Fujimoto
Journal:  Brain Dev       Date:  1995 Sep-Oct       Impact factor: 1.961

View more
  5 in total

Review 1.  Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus.

Authors:  Katelin P Patterson; Tallie Z Baram; Shlomo Shinnar
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

2.  The baseline risk of multiple febrile seizures in the same febrile illness: a meta-analysis.

Authors:  Christopher Henry; Chelsea Cockburn; Mary Helen Simpson; Serenity Budd; Chen Wang; Darina Dinov
Journal:  Eur J Pediatr       Date:  2022-03-16       Impact factor: 3.860

3.  Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children.

Authors:  Daniel C Payne; James Baggs; Danielle M Zerr; Nicola P Klein; Katherine Yih; Jason Glanz; Aaron T Curns; Eric Weintraub; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2013-11-20       Impact factor: 9.079

4.  Trends in Rate of Seizure-Associated Hospitalizations Among Children <5 Years Old Before and After Rotavirus Vaccine Introduction in the United Sates, 2000-2013.

Authors:  Kimberly D Pringle; Rachel M Burke; Claudia A Steiner; Umesh D Parashar; Jacqueline E Tate
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 7.759

5.  Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.

Authors:  Veena Hoffman; Remon Abu-Elyazeed; Cheryl Enger; Daina B Esposito; Michael C Doherty; Scott C Quinlan; Kathleen Skerry; Crystal N Holick; Peter Basile; Leonard R Friedland; Nicolas Praet; Stéphanie Wéry; Corinne Willame; David D Dore; Dominique Rosillon
Journal:  Hum Vaccin Immunother       Date:  2018-04-13       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.